PRESS RELEASES
- ALL
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
-
July 26, 2023
Forward Pharma Closes Round A+ Financing And Continues To Move Forward With 2 Clinical Stage Assets
-
March 23, 2023
Forward Pharma Wins New Honor Of "SRDI Small- & Medium-sized Enterprise"
-
December 16, 2022
Forward Pharma Wins 7.75 Million Award From Shenzhen Government Funds
-
November 30, 2022
FWD1509 Wins Product-of-Excellence Award For The Third Time At China Hi-tech Fair (Chtf)
-
September 3, 2021
Forward Pharma Raises 100 million in Series A, led by CSPC and Xian Tong Fund
-
June 8, 2021
FWD1509, A Targeted Therapy For Certain EGFR/HER2 Mutants, Is Cleared For Ph1 By NMPA
-
May 13, 2021
Forward Pharma Is Selected As One of THE "2020 Guangdong-Hong Kong-Macao Greater Bay Area Innovation Power Enterprises"
-
January 1, 2021
FDA Clears Forward’s Innovative FWD1509 For Ph1
-
November 11, 2020
Forward Pharma Makes Debut At Annual International High-Tech Fair
-
December 27, 2019
Shenzhen Forward Pharma Is Developing A New Targeted Therapy For Treating EGFR-mutated Lung Cancer
-
July 24, 2018
Forward Pharma Joins Hands With Tsinghua University Shenzhen Research Institute To Establish "Cancer Innovative Drug Research And Development Center"
-
December 18, 2017
Forward Pharma Takes Home 2nd Place In The "Star Of Entrepreneurship" Competition
-
July 26, 2023
Forward Pharma Closes Round A+ Financing And Continues To Move Forward With 2 Clinical Stage Assets
-
March 23, 2023
Forward Pharma Wins New Honor Of "SRDI Small- & Medium-sized Enterprise"
-
December 16, 2022
Forward Pharma Wins 7.75 Million Award From Shenzhen Government Funds
-
November 30, 2022
FWD1509 Wins Product-of-Excellence Award For The Third Time At China Hi-tech Fair (Chtf)
-
September 3, 2021
Forward Pharma Raises 100 million in Series A, led by CSPC and Xian Tong Fund
-
June 8, 2021
FWD1509, A Targeted Therapy For Certain EGFR/HER2 Mutants, Is Cleared For Ph1 By NMPA
-
May 13, 2021
Forward Pharma Is Selected As One of THE "2020 Guangdong-Hong Kong-Macao Greater Bay Area Innovation Power Enterprises"
-
January 1, 2021
FDA Clears Forward’s Innovative FWD1509 For Ph1